Pharmaceuticals

Merck KGaA Streamlines Healthcare Management

Lubrizol Acquires Particle Sciences

Topics • Strategy

Poised For Growth

Valeant to Acquire Sprout and Enter Sexual Health Market

GSK Says Drugs from Closed Plant Safe

Topics • Chemistry

A Whole New Range of New Services

Topics • Chemistry

‘A Right to Play and a Right to Win’

Pfizer Speculated to Have GSK in its Sights

J&J Drugs Arm Announces 10 Blockbuster Filings by 2019

J&J Settles Risperdal Lawsuit for $7.8 Million

PwC Sees Pharmaceuticals, Life Sciences in M&A Surge

Alexion Paying $8.4 Billion to Acquire Synageva

Santen’s Eye Treatment First to Get European Approval

Endo International Tries to Spoil Valeant’s Salix Deal

Topics • Strategy

Drugs Industry Battered by Currency and Competition

New Sanofi Chief’s “Welcome Bonus” Slammed

Actavis Changing Name to Allergan

Topics • Chemistry

Chemtura Organometallics Confidently Enters 2015

Germany’s Merck and FlexEnable Find Plastic LCD

Topics • Strategy

Building Momentum

Topics • Strategy

Camelot’s Pharma Management Radar

Topics • Technology

From Experts for Experts

Topics • Strategy

The Formula For Success

BASF to Lift Chinese Tertiary Butylamine Output

GSK Soon to Start Ebola Vaccine Trials

Topics • Strategy

Accelerating the Benefits Achievable from Biocatalysis

Topics • Strategy

CPhI 2014 Experts Statements: Dr. Max Braun and Nicolas Taillardat, Solvay

Topics • Strategy

CPhI 2014 Experts Statements: Dr. Michael Stohlmeier, Senior Product Manager — Business Development, CU Chemie Uetikon

Topics • Strategy

CPhI 2014 Experts Statements: Ian Muir. Managing Director, Finished Dose, Aesica

Topics • Strategy

Today’s Challenges, Tomorrow’s Excellence

Moody Reviews German Merck’s Credit Rating

China Fines GSK Nearly $500 Million on Bribery Charges

Merck KGaA to Buy Sigma-Aldrich for $17 billion

Topics • Strategy

M&A in Chemicals & Pharmaceuticals

Topics • Strategy

Building a Future-Proof Business

421 more articles

Top-Feature

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

Modular Automation Moves from Vision to GMP Reality

Predictive Simulation in Pharma Production

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

CPA Chemical Pharmac. Ass.

Cedarburg Hauser Pharmaceuticals

High Technology Associates

WeylChem International GmbH

Clea Technologies B.V.

Berlin Partner für Wirtschaft und Technologie GmbH

Informa Markets

Cerbios-Pharma SA

Simon-Kucher & Partners Strategy & Marketing Consultants GmbH

Chemical Market Reporter

American Chemistry Council

Helsinn Chemicals SA

Oracle Germany

Chemtura Corp.

Robert Bosch GmbH

Chemgineering Technology GmbH

EquipNet Inc.

Camelot Management Consultants AG

Cambrex Corporation

Dechema e.V.

Porsche Consulting

Saltigo GmbH

Bio Evaluation

Society of Chemical Manufacturers & Affiliates (SOCMA)

A.T. Kearney GmbH

Arthur D. Little

Thomson Reuters

Dr. Partsch & Partner

Sustainability Support Services (Europe) AB